Curative Health Services to Report Second Quarter 2004 Results.

HAUPPAUGE, N.Y. -- Curative Health Services, Inc., (Nasdaq: CURE), will hold a conference call to discuss the Company's second quarter 2004 financial results, recent developments, business strategy and outlook on Wednesday, August 4, 2004, at 11:00 a.m. Eastern Time. To participate in the conference call, dial 1-800-500-0177 approximately 10 minutes prior to the scheduled start time.

If you are unable to participate, a digital replay of the call will be available from August 4, 2004 at 1:00 p.m. Eastern Time until 11:59 p.m. Eastern Time on August 10, 2004 by dialing 1-888-203-1112 with passcode #218276. The live broadcast of Curative Health Services quarterly conference call will be available online by going to www.curative.com and selecting the Investor Relations link, on www.streetevents.com, and on www.companyboardroom.com. An online replay will be available shortly after the call through August 10, 2004 at those sites.

About Curative Health Services

Curative Health Services, Inc., through its two business units, Specialty Infusion and Wound Care Management, seeks to deliver high-quality care and clinical results that result in high patient satisfaction for patients experiencing serious or chronic medical conditions.

Curative's Specialty Infusion business unit provides biopharmaceuticals and compounded pharmaceutical products to patients with chronic and critical disease states and related clinical services to assist these patients with their intensive disease management needs. The products distributed and the injection or infusion therapies offered by the Specialty Infusion business unit are used by patients with chronic or severe conditions such as hemophilia, immune systems disorders, chronic or severe infections, gastrointestinal illnesses that prohibit oral digestion and other severe conditions requiring nutritional support, respiratory syncytial virus, cancer, rheumatoid arthritis, hepatitis C, multiple sclerosis or growth hormone deficiency.

Curative's Wound Care Management business unit is a leading disease management company specializing in chronic wound care management. The Wound Care Management business unit manages, on behalf of hospital clients, a nationwide network of Wound Care Center(R) programs that offer a comprehensive range of services for treatment of chronic wounds.

For more information, visit www.curative.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such differences include, but are not limited to, risks associated with our acquisition of Critical Care Systems including, but not limited to, integration risks and costs, risks of client retention, risks associated with the operations of the acquired business, as well as risks in our current businesses such as the termination or non-renewal of a material number of contracts, an inability to obtain new contracts, changes in the government regulations relating to the Company's Specialty Infusion or Wound Care Management business units, changes in the regulations governing third party reimbursements for the Company's services, manufacturing shortages of products sold by Curative's Specialty Infusion business unit, and the other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. Readers of this release are referred to the Company's Registration Statement on Form S-4 filed July 9, 2004, for further discussion of these and other risk factors that could affect future results.